Clinical Trial Update: Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Jumpvax, an immunotherapy with inulin as adjuvant, exploring sting challenge and serological responses in ant sting immunotherapy (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ant Sting

Drugs mentioned

• Jumpvax

Snippet

Sponsor: Central Adelaide Local Health Network Incorporated | Conditions: Ant Sting, Immunotherapy | Phase 1, Phase 2 | Status: UNKNOWN